Author(s):
Madhuri T. Deshmukh, Pavan G. Ingole, Mahesh R. Sharma, Tushar N. Gite
Email(s):
pavaningole05@gmail.com
DOI:
10.52711/2231-5691.2025.00048 
Address:
Madhuri T. Deshmukh1, Pavan G. Ingole2*, Mahesh R. Sharma2, Tushar N. Gite2
1Associate Professor, Smt. Kashibai Navale College of Pharmacy, Kondhwa, Pune, Maharashtra, India.
2Research Scholar, Smt. Kashibai Navale College of Pharmacy, Kondhwa, Pune, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 15,
Issue - 3,
Year - 2025
ABSTRACT:
The absorption, bioavailability, and therapeutic efficacy of pharmacologically active compounds are fundamentally dependent upon their solubility. Several newly synthesised compounds have inadequate water solubility, presenting a significant challenge, particularly for orally administered pharmaceuticals, as low solubility may result in reduced absorption and thus reduced therapeutic efficacy. Pharmaceutical research primarily tackles this issue, leading to the development of several solubility enhancement strategies. among the frequently examined techniques, solid dispersions exhibit significant potential. To enhance solubility and bioavailability, these formulations disperse poorly soluble pharmaceuticals within an inert medium. achieving uniform dispersion and maintaining stability is challenging. Nanocrystal technology, which provides a self-dispersing medication delivery system, has been extensively studied. Nanocrystals increase solubility and bioavailability by increasing surface area and dissolution rates. Their application has particularly facilitated the more effective dissolution of hydrophobic pharmaceuticals. A recognised method for enhancing water solubility is the creation of salt. Pharmacists have significantly advanced solubility and therapeutic outcomes by converting poorly soluble medications into their salt forms. Micronization enhances solubility by increasing the surface area available for dissolution, as it reduces medication particle size to the micron scale. Cyclodextrins, cyclic oligosaccharides, have demonstrated the ability to form inclusion complexes with hydrophobic pharmaceutical compounds when their solubility and stability are investigated. moreover, lipid-based formulations, such as amorphous solid dispersions and self-emulsifying drug delivery systems (SEDDS), are receiving heightened attention for their capacity to enhance solubility. Additionally, nanotechnology-based drug delivery utilising polymeric nanoparticles and liposomes is under investigated as a potential approach. These innovative techniques offer compelling strategies to enhance medication solubility, stability, and bioavailability.
Cite this article:
Madhuri T. Deshmukh, Pavan G. Ingole, Mahesh R. Sharma, Tushar N. Gite. Enhancing the Solubility of Poorly Soluble Drugs: Strategies and Advances in Pharmaceutical Formulations. Asian Journal of Pharmaceutical Research. 2025; 15(3):309-5. doi: 10.52711/2231-5691.2025.00048
Cite(Electronic):
Madhuri T. Deshmukh, Pavan G. Ingole, Mahesh R. Sharma, Tushar N. Gite. Enhancing the Solubility of Poorly Soluble Drugs: Strategies and Advances in Pharmaceutical Formulations. Asian Journal of Pharmaceutical Research. 2025; 15(3):309-5. doi: 10.52711/2231-5691.2025.00048 Available on: https://www.asianjpr.com/AbstractView.aspx?PID=2025-15-3-12
REFERENCES:
1. Sharma N, Bharkatiya M. Solubility Enhancement Techniques: A Review. Int J Pharm Erudition. 2011 Nov;1(3):40-53.
2. Argade PS, Magar DD, Saudagar RB. Solid Dispersion: Solubility Enhancement Technique for Poorly Water-Soluble Drugs. J Adv Pharm Edu Res. 2013; 3(4):1-13.
3. Kumar A, Rajesh M, Subramanian L. Solubility enhancement techniques: A comprehensive review. World Journal of Biology Pharmacy and Health Sciences. 2023;13(3):141-1491.
4. Kumari L, Choudhari Y, Patel P, Gupta GD, Singh D, Rosenholm JM, et al. Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs. Life (Basel). 2023;13(5):1099
5. Mallik T, Banerjee D. Solvation and Solvatochromism: An Overview. Indian J Chem. 2022; 61: 472-481.
6. Shukla S, Sharma PK. A Review on Solubility Enhancement Techniques. Int J Pharm Res. 2020; 19(1): 1-10.
7. Moreton C. Poor Solubility – Where Do We Stand 25 Years after the ‘Rule of Five’? American Pharmaceutical Review. 2021; 24: 1-5.
8. Schreier S, Malheiros V.P., de Paula E. Review Surface Active Drugs: Self-Association and Interaction with Membranes and Surfactants. Biochimica et Biophysica Acta. 2000; 1508(1): 210-234.
9. Jagtap S, Magdum C, Jadge D, Jagtap R. Solubility Enhancement Technique: A Review. J Pharm Res. 2020; 19(1): 1-10
10. Coltescu AR, Butnariu M, Sarac I. The Importance of Solubility for New Drug Molecules. Biomed Pharmacol J. 2020; 13(2): 1-10.
11. Singhal P, Singhal RV, Kumar VJ, Verma A, Kaushik RD. The Biopharmaceutics Classification System (BCS): Review. World J Pharm Sci. 2017; 7(1): 269-283.
12. Swathi Divakar, Mahesh Padaki, and R. Geetha Balakrishna. Review on Liquid-Liquid Separation by Membrane Filtration. ACS Omega. 2022; 7: 44495-44506.
13. B.A. Bhairav, J.K. Bachhav, R.B. Saudagar. Review on Solubility Enhancement Techniques. Asian J. Pharm. Res. 2016; 6(3): 147-152.
14. Rossier B, Jordan O, Allemann E, Rodríguez-Nogales C. Nanocrystals and nanosuspensions: an exploration from classic formulations to advanced drug delivery systems. Drug Delivery and Translational Research 2024; 14: 3438-3451.
15. Raza K, Kumar P, Ratan S, Malik R, Arora S. Polymorphism: The Phenomenon Affecting the Performance of Drugs. Symbiosis 2014; 8(1): 1-10
16. Vyas A, Gidwani B. Technologies to Counter Poor Solubility Issues: A Review. Research J. Pharm. and Tech. 2013; 6(11): 1258-1270
17. Bhaduka G, Rajawat J. S. Formulation Development and Solubility Enhancement of Voriconazole by Solid Dispersion Technique. Research J. Pharm. and Tech. 2020; 13(10): 4557-4564.
18. Patil H, Vemula SK, Narala S, et al. Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation. AAPS PharmSciTech. 2024; 25(2): 37-49.
19. Frank DS, Punia A, Fahy M, et al. Densifying Co-Precipitated Amorphous Dispersions to Achieve Improved Bulk Powder Properties. Pharmaceutical Research. 2022; 39(10): 3197-3208.
20. Daisy Sharma, Mohit Soni, Sandeep Kumar, GD Gupta. Solubility Enhancement – Eminent Role in Poorly Soluble Drugs. Research J. Pharm. and Tech. 2009; 2(2): 220-224.
21. Shinde JV, Orpe AA, Munde VP, et al. Self-Micro-Emulsifying Drug Delivery System (SMEDDS) - A Novel Approach. American Journal of PharmTech Research. 2020; 10(1): 1-10.
22. Mishra R, Gautam S.S., Raj K. Prasad, A. K. Patel, A. K. Sahu. Solubility Enhancement of Clarithromycin Using Solid Dispersion and Effervescence Assisted Fusion Technique. Research J. Pharm. and Tech. 2016; 9(6): 677-686.
23. Aditya Sharma, Vaibhav Rastogi, Prevesh Kumar, Neelkant Prasad. Formulation Approaches for Solubility Enhancement by Using Polar or Non-Polar Lipid Components of BCS Class II Drugs through LBDDS. Research J. Pharm. and Tech. 2020; 13(8): 3918-3928
24. Choudhary AN, Nayal S. A review: Hydrotropy a solubility enhancing technique. The Pharma Innovation Journal. 2019; 8(4): 1149-1153.
25. Zhuo Y, Zhao Y-G, Zhang Y. Enhancing Drug Solubility, Bioavailability, and Targeted Therapeutic Applications through Magnetic Nanoparticles. Molecules. 2024; 29(20): 4854.